980 resultados para Richard, Maurice


Relevância:

80.00% 80.00%

Publicador:

Relevância:

60.00% 60.00%

Publicador:

Resumo:

"Variorum readings of 'Leaves of grass', ed. by Oscar Lovell Triggs, PH.D.": v. 3, p. [83]-[255]

Relevância:

30.00% 30.00%

Publicador:

Resumo:

Cette version de la thèse a été tronquée des certains éléments protégés par le droit d’auteur. Une version plus complète est disponible en ligne pour les membres de la communauté de l’Université de Montréal et peut aussi être consultée dans une des bibliothèques UdeM.

Relevância:

30.00% 30.00%

Publicador:

Resumo:

bk. I. The book of Yea.--bk. II. The book of Nay.

Relevância:

30.00% 30.00%

Publicador:

Resumo:

Mode of access: Internet.

Relevância:

30.00% 30.00%

Publicador:

Resumo:

Bk. I. The book of Yea.--Bk. II. The book of Nay.

Relevância:

30.00% 30.00%

Publicador:

Resumo:

"Les pages qui suivent ont d'abord paru dans Le guide musical": p. [5]

Relevância:

30.00% 30.00%

Publicador:

Resumo:

First series "limited to six hundred copies."

Relevância:

20.00% 20.00%

Publicador:

Resumo:

The aim of a clinical classification of pulmonary hypertension (PH) is to group together different manifestations of disease sharing similarities in pathophysiologic mechanisms, clinical presentation, and therapeutic approaches. In 2003, during the 3rd World Symposium on Pulmonary Hypertension, the clinical classification of PH initially adopted in 1998 during the 2nd World Symposium was slightly modified. During the 4th World Symposium held in 2008, it was decided to maintain the general architecture and philosophy of the previous clinical classifications. The modifications adopted during this meeting principally concern Group 1, pulmonary arterial hypertension (PAH). This subgroup includes patients with PAH with a family history or patients with idiopathic PAH with germline mutations (e. g., bone morphogenetic protein receptor-2, activin receptor-like kinase type 1, and endoglin). In the new classification, schistosomiasis and chronic hemolytic anemia appear as separate entities in the subgroup of PAH associated with identified diseases. Finally, it was decided to place pulmonary venoocclusive disease and pulmonary capillary hemangiomatosis in a separate group, distinct from but very close to Group 1 (now called Group 1`). Thus, Group 1 of PAH is now more homogeneous. (J Am Coll Cardiol 2009;54:S43-54) (C) 2009 by the American College of Cardiology Foundation